Genelux Corporation (GNLX) Profit Margin
Genelux Corporation (GNLX) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2023-12-31 | -16645.29% |
| 2024-12-31 | -373362.50% |
| 2025-12-31 | -401812.50% |
How GNLX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| PLSE | Pulse Biosciences Inc | -20794.57% |
| BNTC | Benitec Biopharma Inc. | -26082.67% |
| INMB | INmune Bio Inc. | -91800.00% |
| INO | Inovio Pharmaceuticals Inc. | -130000.00% |
| ALT | Altimmune Inc. | -214860.98% |
These are five companies in the same sector as GNLX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Genelux Corporation Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("GNLX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | GNLX | $2.74 | +2.24% | 0.41M |
| 3 | ||||
| 4 | ||||
| 5 |